Search

Displaying all 10 results
DrugBest match

Empagliflozin

go.drugbank.com/drugs/DB09038
ApprovedInvestigational

Empagliflozin is an inhibitor of sodium-glucose co-transporter-2 (SGLT2), the transporters primarily responsible for the reabsorption of glucose in the kidney. It is used clinically as an adjunct to diet and exercise, often in combination with other drug therapies, for the management of type 2 diabetes mellitus. The...

  1. Drug

    Linagliptin

    go.drugbank.com/drugs/DB08882
    ApprovedInvestigational

    Linagliptin is a DPP-4 inhibitor developed by Boehringer Ingelheim for the treatment of type II diabetes . Linagliptin differs from other DPP-4 inhibitors in that it has a non-linear pharmacokinetic profile, is not primarily eliminated b...

    Mixtures: Glyxambi Film-Coated Tablets 25mg/5mg (Empagliflozin 25mg/ Linagliptin 5mg), Glyxambi Film-Coated Tablets 10mg/5mg (Empagliflozin 10mg / Linagliptin 5mg)Categories: linagliptin and empagliflozin, metformin, linagliptin and empagliflozin
  2. Indication

    Chronic Kidney Disease (CKD)

    go.drugbank.com/conditions/DBCOND0048800
    Drugs: Empagliflozin · Tenapanor
  3. Indication

    Symptomatic Congestive Heart Failure

    go.drugbank.com/conditions/DBCOND0055215
    Drugs: Empagliflozin · Enalapril
  4. Drug

    Metformin

    go.drugbank.com/drugs/DB00331
    ApprovedInvestigational

    Metformin is a biguanide antihyperglycemic agent and first-line pharmacotherapy used in the management of type II diabetes. Metformin is considered an antihyperglycemic drug because it lowers blood glucose concentrations in type II diabe...

    Categories: metformin and empagliflozin, metformin, linagliptin and empagliflozin
  5. Indication

    End Stage Renal Disease (ESRD)

    go.drugbank.com/conditions/DBCOND0035540
    Drugs: Canagliflozin · Dapagliflozin · Empagliflozin · Finerenone · Metformin · Semaglutide
  6. Drug

    Avenciguat

    go.drugbank.com/drugs/DB18882
    Investigational

    Avenciguat is under investigation in clinical trial NCT05282121 (A Study to Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis

  7. Drug

    Vicadrostat

    go.drugbank.com/drugs/DB21693
    Investigational

    Vicadrostat is under investigation in clinical trial NCT07064473 (A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular

  8. Indication

    Cardiovascular Mortality

    go.drugbank.com/conditions/DBCOND0040959
    Drugs: Acetylsalicylic acid · Canagliflozin · Colchicine · Dapagliflozin · Empagliflozin · Evolocumab +12 more
  9. Indication

    Type 2 Diabetes

    go.drugbank.com/conditions/DBCOND0030616
    Drugs: Acarbose · Albiglutide · Alogliptin · Bexagliflozin · Bromocriptine · Canagliflozin +40 more